Zubaid Mohammad, Rashed Wafa A, Saad Hisham, Attiya Ali, Al-Banat Bassam Abu, Ridha Mustafa, Al-Kandari Muhammad H, Baidas Ghassan, Al-Hamdan Rashed, Zubair Shaheed, Thalib Lukman
Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait.
Med Princ Pract. 2007;16(6):407-12. doi: 10.1159/000107732.
To identify the characteristics of patients with acute coronary syndromes (ACS), their hospital management and in-hospital outcomes, through a prospective registry system in Kuwait.
A registry involving all 7 general hospitals in Kuwait was set up. Consecutive patients diagnosed as having ACS over a period of 6 months were enrolled.
Of 2,129 patients enrolled, 718 (34%) had ST segment elevation myocardial infarction (STEMI), 576 (27%) non-ST segment elevation myocardial infarction (NSTEMI) and 835 (39%) unstable angina (UA). Thrombolytic therapy was used in 556 (77%) patients with STEMI. The median time from diagnostic electrocardiogram to administration of thrombolytic therapy was 38 min. Almost all patients with ACS (2,050, 96%) received aspirin during hospitalization. Only a minority received clopidogrel, 18 (3%) STEMI, 36 (6%) NSTEMI and 96 (12%) UA patients. The use of glycoprotein IIb/IIIa antagonists was minimal (38 patients, 2%). beta-Blockers were used in 1,473 (69%) patients, while 982 (46%) received angiotensin-converting enzyme inhibitors. Coronary angiography during hospitalization was performed in 119 (17%), 120 (21%) and 126 (15%) patients with STEMI, NSTEMI and UA, respectively. In-hospital mortality occurred in 31 (4%) myocardial infarction patients and 4 (0.5%) UA patients (p < 0.0001).
This registry has enabled us to determine the incidence and characteristics of ACS patients in Kuwait. It has also enabled us to identify some barriers that we need to overcome for the full implementation of published guidelines for the management of patients with ACS.
通过科威特的一个前瞻性登记系统,确定急性冠状动脉综合征(ACS)患者的特征、住院治疗情况及住院结局。
建立了一个涵盖科威特所有7家综合医院的登记系统。纳入连续6个月内诊断为ACS的患者。
在纳入的2129例患者中,718例(34%)为ST段抬高型心肌梗死(STEMI),576例(27%)为非ST段抬高型心肌梗死(NSTEMI),835例(39%)为不稳定型心绞痛(UA)。556例(77%)STEMI患者接受了溶栓治疗。从诊断心电图到给予溶栓治疗的中位时间为38分钟。几乎所有ACS患者(2050例,96%)在住院期间都接受了阿司匹林治疗。只有少数患者接受了氯吡格雷治疗,其中STEMI患者18例(3%),NSTEMI患者36例(6%),UA患者96例(12%)。糖蛋白IIb/IIIa拮抗剂的使用极少(38例患者,2%)。1473例(69%)患者使用了β受体阻滞剂,982例(46%)患者接受了血管紧张素转换酶抑制剂治疗。STEMI、NSTEMI和UA患者分别有119例(17%)、120例(21%)和126例(15%)在住院期间接受了冠状动脉造影。心肌梗死患者中有31例(4%)发生住院死亡,UA患者中有4例(0.5%)发生住院死亡(p<0.0001)。
该登记系统使我们能够确定科威特ACS患者的发病率和特征。它还使我们能够识别出在全面实施已发表的ACS患者管理指南过程中需要克服的一些障碍。